Cargando…
Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases
Background and Aims. Deoxyribonuclease I (DNaseI) is an endonuclease that facilitates chromatin breakdown and promotes susceptibility to autoimmune disorders. The aim of current study was to investigate serum DNase I activity in patients with inflammatory bowel diseases (IBD). Patients and Methods....
Autores principales: | Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Hrušková, Zdenka, Svobodová, Barbora, Machková, Naděžda, Komárek, Viktor, Fučíková, Terezie, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112520/ https://www.ncbi.nlm.nih.gov/pubmed/21687600 http://dx.doi.org/10.4061/2011/945861 |
Ejemplares similares
-
Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases
por: Malíčková, Karin, et al.
Publicado: (2012) -
Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers
por: Malíčková, Karin, et al.
Publicado: (2017) -
ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
por: Cerna, Karin, et al.
Publicado: (2022) -
Deoxyribonucleases and Their Applications in Biomedicine
por: Lauková, Lucia, et al.
Publicado: (2020) -
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study
por: Mitrova, Katarina, et al.
Publicado: (2021)